中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Predicting Aneurysm Growth and Rupture With Longitudinal Biomarkers

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态招聘中
赞助商
Ron Balm
合作者
Parelsnoer Institute the Netherlands

关键词

抽象

First aim: PARIS study
The main aim of the current study is to determine the association between abdominal aortic aneurysm (AAA) progression and the evolution of proteases and cytokines levels.To achieve this aim, we will prospectively collect blood, aortic tissue, patient data, and imaging data. Aortic tissue will only be obtained when patients undergo conventional open repair. The other biomaterials will be collected during regular patient follow-up visits, with a maximum frequency of once per year.
Second aim: Pearl AAA biobank
For future research purposes, a new biobanking infrastructure will be created to collect and store additional blood and urine samples in a biobank. This biobank will be embedded within the infrastructure of the 'Parelsnoer Institute' (PSI) and will be called Pearl AAA. The Pearl AAA will be established in the extension of the PARIS study

描述

The PARIS study aims to determine the correlation between AAA progression (growth or rupture) and the evolution of serum levels of proteases and cytokines over time. A repeated measures analysis will be done to use all longitudinal data available.

The Pearl AAA biobank will be established to enable the PARIS study, but also aims to facilitate future research. Such future research should fall under the scientific aims of the Pearl AAA, which are:

- To gain insight in the pathogenesis of AAA

- To gain more knowledge in the rupture risk of AAA

- To evaluate and potentially improve treatment of AAA

The 'Parelsnoer Institute' will facilitate the biobank Pearl AAA with certain aspects such as, but not limited to the following:

- Standardized operating procedures for the collection and storage of the biosamples across all participating hospitals

- Information architect to establish a data dictionary in which all variables are defined

- Standardized procedures for coding of patient data before storage

- Standardized digital infrastructure to enhance storage of patient data and imaging data

日期

最后验证: 06/30/2020
首次提交: 10/11/2017
提交的预估入学人数: 10/22/2017
首次发布: 10/24/2017
上次提交的更新: 07/08/2020
最近更新发布: 07/09/2020
实际学习开始日期: 10/03/2017
预计主要完成日期: 10/03/2032
预计完成日期: 10/03/2032

状况或疾病

Abdominal Aortic Aneurysm
Abdominal Aortic Aneurysm, Ruptured

-

手臂组

干预/治疗
Asymptomatic AAA
These patients will be included while their AAA is asymptomatic and while they are under surveillance by their vascular surgeon.
Acute AAA
These are the patients that are included while they presented in the participating hospitals because either a symptomatic or ruptured AAA. For this group, a different recruitment procedure exists which has been approved by the appropriate medical ethical committee.
Repaired AAA
These patients are included while they already had had AAA repair (both elective and emergency repair).

资格标准

有资格学习的年龄 18 Years 至 18 Years
有资格学习的性别All
取样方式Probability Sample
接受健康志愿者
标准

Inclusion Criteria:

- Adult participant (18 years or older)

- Participant has an AAA or has previously been treated for an AAA

- Adequate comprehension of the Dutch language to provide written informed consent

Exclusion Criteria:

- A patient who is decisionally impaired. The only exception to this are the patients who are decisionally impaired due to the effects of an acute AAA. This particular group is eligible for which a separate recruitment and consent procedure exists.

结果

主要结果指标

1. AAA growth [Up to 10 years of follow-up]

Growth of abdominal aortic aneurysm, measured on imaging made for clinical purposes

2. AAA rupture [Up to 10 years of follow-up]

Rupture of an abdominal aortic aneurysm

3. Death [Up to 10 years of follow-up]

All-cause mortality

4. Evolution of serum levels of proteases [a maximum of 1 measurement annually up to 10 years of follow-up]

Repeated measurements analysis of serum levels of proteases in cohort of asymptomatic AAAs

5. Evolution of serum levels of cytokines [a maximum of 1 measurement annually up to 10 years of follow-up]

Repeated measurements analysis of serum levels of cytokines in cohort of asymptomatic AAAs

6. Protease levels in aortic tissue [If open AAA repair is performed and aortic tissue is collected, protease levels will then be measured. This is a one-time measurement.]

Protease levels in aortic tissue

7. Cytokine levels in aortic tissue [If open AAA repair is performed and aortic tissue is collected, cytokine levels will then be measured. This is a one-time measurement.]

Cytokine levels in aortic tissue

次要成果指标

1. Type of complications after AAA repair [Will be measured up to 10 years after AAA repair is performed]

Type of complications using methodology from the Dutch committee of the "Nederlandse Vereniging voor Heelkunde," named the "Landelijke Heelkunde Complicatie Registratie" as found on www.lhcr.nl

2. Incidence of complications after AAA repair [Will be measured up to 10 years after AAA repair is performed]

Number of complications after abdominal aortic aneurysm repair

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge